(Q43546813)

24 November 2017

title

Clinical relevance of lower Hib response in DTPa-based combination vaccines (English)

1 reference

ORCID Public Data File 2021

24 November 2017

1 reference

author name string

Poolman J

1 reference

24 November 2017

Kaufhold A

1 reference

24 November 2017

De Grave D

1 reference

24 November 2017

Goldblatt D

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

24 November 2017

1 reference

24 November 2017

1 reference

24 November 2017

issue

17-19

1 reference

24 November 2017

page(s)

2280-2285

1 reference

Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

Passive immunization against disease due to Haemophilus influenzae type b: concentrations of antibody to capsular polysaccharide in high-risk children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheria-tetanus-acellular pertussis-hib-hepatitis B combined vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900517-X

7 January 2021

10.1016/S0264-410X(00)00517-X

Identifiers

DOI

1 reference

24 November 2017

1 reference